Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants

Clinical trial NCT07236411 · COMPLETED

Trial details

NCT number: NCT07236411
Sponsor: Candid Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Study

Start date: 2025-12-04
Primary completion: 2026-04-16
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.